PDS Planning Inc Has $253,000 Stock Holdings in Colgate-Palmolive (NYSE:CL)

PDS Planning Inc reduced its stake in Colgate-Palmolive (NYSE:CL) by 4.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,781 shares of the company’s stock after selling 121 shares during the quarter. PDS Planning Inc’s holdings in Colgate-Palmolive were worth $253,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Mystic Asset Management Inc. lifted its stake in shares of Colgate-Palmolive by 4.5% in the fourth quarter. Mystic Asset Management Inc. now owns 24,135 shares of the company’s stock worth $2,194,000 after acquiring an additional 1,038 shares during the period. Axxcess Wealth Management LLC lifted its stake in shares of Colgate-Palmolive by 0.3% in the fourth quarter. Axxcess Wealth Management LLC now owns 38,786 shares of the company’s stock worth $3,526,000 after acquiring an additional 117 shares during the period. Flagship Wealth Advisors LLC acquired a new position in shares of Colgate-Palmolive in the fourth quarter worth approximately $100,000. Cibc World Markets Corp lifted its stake in shares of Colgate-Palmolive by 20.7% in the fourth quarter. Cibc World Markets Corp now owns 318,671 shares of the company’s stock worth $28,970,000 after acquiring an additional 54,683 shares during the period. Finally, SlateStone Wealth LLC lifted its stake in shares of Colgate-Palmolive by 3.6% in the fourth quarter. SlateStone Wealth LLC now owns 10,873 shares of the company’s stock worth $988,000 after acquiring an additional 375 shares during the period. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Trading Up 1.1 %

Shares of Colgate-Palmolive stock opened at $90.44 on Thursday. The stock has a fifty day simple moving average of $89.19 and a 200 day simple moving average of $94.41. Colgate-Palmolive has a 12-month low of $85.32 and a 12-month high of $109.30. The company has a market capitalization of $73.39 billion, a P/E ratio of 25.69, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the previous year, the company earned $0.87 EPS. On average, sell-side analysts anticipate that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts recently commented on CL shares. Barclays cut their price objective on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research note on Friday, January 17th. Wells Fargo & Company dropped their price target on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research note on Tuesday, January 7th. TD Cowen dropped their price target on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research note on Wednesday, January 8th. Royal Bank of Canada reissued a “sector perform” rating and issued a $101.00 price target on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. Finally, Morgan Stanley dropped their price target on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a research note on Monday, February 3rd. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating and eleven have assigned a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $101.72.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.